On July 2, 2024, Amy Vaccine Co., Ltd. submitted the latest securities change monthly report to the Hong Kong Stock Exchange and Clearing Limited, covering the situation as of June 30, 2024. The report shows that the number of legal/registered H shares and legal/registered domestic shares of the company remains at 492,173,711 shares and 718,888,888 shares, respectively, with no changes. In addition, the number of issued shares (excluding treasury shares) of the company also remains unchanged, with 492,173,711 H shares and 718,888,888 domestic shares. The company also reported changes in the stock option plan, where 75,000 stock options of the first employee share incentive plan before the initial public offering were cancelled this month, and the balance is 3,201,000 stock options. Amy Vaccine confirmed that all issuances or sales/transfers of treasury shares have been authorized by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.

On July 2, 2024, Amy Vaccine Co., Ltd. submitted the latest securities change monthly report to the Hong Kong Stock Exchange and Clearing Limited, covering the situation as of June 30, 2024. The report shows that the number of legal/registered H shares and legal/registered domestic shares of the company remains at 492,173,711 shares and 718,888,888 shares, respectively, with no changes. In addition, the number of issued shares (excluding treasury shares) of the company also remains unchanged, with 492,173,711 H shares and 718,888,888 domestic shares. The company also reported changes in the stock option plan, where 75,000 stock options of the first employee share incentive plan before the initial public offering were cancelled this month, and the balance is 3,201,000 stock options. Amy Vaccine confirmed that all issuances or sales/transfers of treasury shares have been authorized by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.